State of the Art Conference 2018 of the European Society of Gynaecological Oncology Lyon, France October 4–6, 2018

2018 ◽  
Vol 28 (Suppl 3) ◽  
pp. 1-267 ◽  
Keyword(s):  
European Society ◽  
State Of The Art ◽  
Gynaecological Oncology

Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting

2021 ◽  
Vol 31 (5) ◽  
pp. 658-669
Author(s):  
Zoia Razumova ◽  
Nicolò Bizzarri ◽  
Joanna Kacperczyk-Bartnik ◽  
Andrei Pletnev ◽  
Antonio Gonzalez Martin ◽  
...  
Keyword(s):  
European Society ◽  
State Of The Art ◽  
Opinion Leaders ◽  
European Network ◽  
Case Presentation ◽  
Gynaecological Oncology ◽  
Virtual Meeting ◽  
Different Types ◽  
Cancer Guidelines ◽  
First Time

This is a report from the European Society of Gynaecological Oncology State-of-the-Art Virtual Meeting held December 14–16, 2020. The unique 3-day conference offered comprehensive state-of-the-art summaries on the major advances in the treatment of different types of gynecological cancers. Sessions opened with a case presentation followed by a keynote lecture and interactive debates with opinion leaders in the field. The speakers also presented scientific reviews on the clinical trial landscape in collaboration with the European Network of Gynecological Oncological Trial (ENGOT) groups. In addition, the new ESGO-ESRTO-ESP endometrial cancer guidelines were officially presented in public. This paper describes the key information and latest studies that were presented for the first time at the conference.

Report From the 20th Meeting of the European Society of Gynaecological Oncology (ESGO 2017)

2018 ◽  
Vol 28 (5) ◽  
pp. 1050-1053 ◽  
Author(s):  
Kamil Zalewski ◽  
Elisa Piovano ◽  
Zoia Razumova ◽  
Ilker Selcuk ◽  
Tanja Nikolova
Keyword(s):  
Translational Research ◽  
European Society ◽  
State Of The Art ◽  
Gynecological Cancers ◽  
Poster Abstract ◽  
Scientific Level ◽  
Cervical Cancers ◽  
Gynaecological Oncology ◽  
Emerging Trends ◽  
First Time

AbstractThis is a report from the 20th Meeting of the European Society of Gynaecological Oncology (ESGO) held in Vienna, Austria on November 4 to 7, 2017. The conference offered state-of-the-art educational sessions and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also emerging trends, and current innovations in gynecological cancers were discussed. The ESGO-European Society for Radiotherapy and Oncology-European Society of Pathology guidelines on management of cervical cancers were reported for the first time in public. Here, we highlight the key results of the latest trials for gynecological cancers presented for the first time at the ESGO 2017 Meeting and added great value to the congress scientific level.

Jahrestagung der European Society of Gynaecological Oncology (ESGO): Neue Erkenntnisse zum Ovarial- und Endometriumkarzinom

2011 ◽  
Vol 02 (06) ◽  
pp. 272-272
Author(s):  
Bettina Reich
Keyword(s):  
European Society ◽  
Gynaecological Oncology

Beim alle 2 Jahre stattfindenden ESGO-Kongress in Mailand wurde deutlich, dass insbesondere beim Ovarialkarzinom zwar keine Sprunginnovationen zu erwarten sind, aber es stetig – Schritt für Schritt – voran geht. Obwohl das Abschneiden der zielgerichteten Therapie mit Abagovomab enttäuschend ist, zeigen weitere Ergebnisse, dass dieser Therapieansatz durchaus seinen Stellenwert in dieser Indikation besitzt. Entscheidend scheint beim Rückfall das platinfreie Intervall zu sein. Beim Endometriumkarzinom deutet sich an, dass Everolimus eine Bereicherung des therapeutischen Regimes sein könnte.

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

2017 ◽  
Vol 27 (4) ◽  
pp. 832-837 ◽  
Author(s):  
Maaike H.M. Oonk ◽  
François Planchamp ◽  
Peter Baldwin ◽  
Mariusz Bidzinski ◽  
Mats Brännström ◽  
...  
Keyword(s):  
International Development ◽  
European Society ◽  
Vulvar Cancer ◽  
Scientific Evidence ◽  
Local Treatment ◽  
Distant Metastases ◽  
Evidence Based ◽  
Gynaecological Oncology ◽  
Patient Representatives ◽  
Development Group

ObjectiveThe aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology’s mission to improve the quality of care for women with gynecologic cancers across Europe.MethodsThe European Society of Gynaecological Oncology Council nominated an international development group made of practicing clinicians who provide care to patients with vulvar cancer and have demonstrated leadership and interest in the management of patients with vulvar cancer (18 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 181 international reviewers including patient representatives independent from the development group.ResultsThe guidelines cover diagnosis and referral, preoperative investigations, surgical management (local treatment, groin treatment including sentinel lymph node procedure, reconstructive surgery), radiation therapy, chemoradiation, systemic treatment, treatment of recurrent disease (vulvar recurrence, groin recurrence, distant metastases), and follow-up.

Sign in / Sign up

Export Citation Format

Share Document